Related Experiment Video
Updated: Aug 29, 2026
Generation of Maternal Mutants Using zpc:cas9 Knock-in Zebrafish
Published on: July 22, 2025
Knockdown of zebrafish Fancd2 causes developmental abnormalities via p53-dependent apoptosis
Ting Xi Liu1, Niall G Howlett, Min Deng
1Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA.
Abstract:
Mechanisms underlying the multiple developmental defects observed in Fanconi anemia (FA) patients are not well defined. We have identified the zebrafish homolog of human FANCD2, which encodes a nuclear effector protein that is monoubiquitinated in response to DNA damage, targeting it to nuclear foci where it preserves chromosomal integrity. Fancd2-deficient zebrafish embryos develop defects similar to those found in children with FA, including shortened body length, microcephaly, and microophthalmia, which are due to extensive cellular apoptosis. Developmental defects and increased apoptosis in Fancd2-deficient zebrafish were corrected by injection of human FANCD2 or zebrafish bcl2 mRNA, or by knockdown of p53, indicating that in the absence of Fancd2, developing tissues spontaneously undergo p53-dependent apoptosis. Thus, Fancd2 is essential during embryogenesis to prevent inappropriate apoptosis in neural cells and other tissues undergoing high levels of proliferative expansion, implicating this mechanism in the congenital abnormalities observed in human infants with FA.
Insights
Fanconi anemia (FA) is linked to developmental defects. Fancd2 deficiency in zebrafish causes apoptosis and developmental issues, highlighting Fancd2
Area of Science:
- Developmental Biology
- Genetics
- Molecular Biology
Background:
- Fanconi anemia (FA) is a rare genetic disorder characterized by multiple congenital abnormalities and an increased risk of cancer.
- The precise molecular mechanisms driving FA's diverse developmental defects remain incompletely understood.
- FANCD2 is a key protein in DNA repair, but its role in embryonic development is not fully elucidated.
Purpose of the Study:
- To investigate the function of the zebrafish FANCD2 homolog (Fancd2) in embryonic development.
- To elucidate the mechanisms underlying developmental defects in Fancd2-deficient organisms.
- To establish a zebrafish model for studying Fanconi anemia.
Main Methods:
- Identification and characterization of the zebrafish FANCD2 homolog (Fancd2).
- Generation of Fancd2-deficient zebrafish embryos via morpholino knockdown.
- Assessment of developmental phenotypes, cellular apoptosis, and gene expression.
- Rescue experiments involving mRNA injection (human FANCD2, zebrafish bcl2) and p53 knockdown.
Main Results:
- Fancd2-deficient zebrafish embryos exhibit developmental abnormalities mirroring human FA, including microcephaly and microphthalmia.
- These defects are attributed to widespread cellular apoptosis during embryogenesis.
- The observed apoptosis is p53-dependent and can be rescued by restoring Fancd2 function or inhibiting apoptosis pathways.
- Fancd2 is crucial for preventing inappropriate apoptosis in rapidly proliferating embryonic tissues.
Conclusions:
- Fancd2 plays an essential role in preventing p53-dependent apoptosis during zebrafish embryogenesis.
- This mechanism is critical for normal development of neural and other tissues.
- The findings implicate Fancd2's role in preventing embryonic apoptosis as a key factor in the congenital abnormalities seen in human Fanconi anemia patients.
- The zebrafish model provides valuable insights into FA pathogenesis and potential therapeutic strategies.
